全国7省份率先实现生娃基本不花钱

Core Viewpoint - The article discusses the key focus areas for the national medical insurance system in China for 2026, emphasizing the goal of making childbirth essentially free nationwide and enhancing the overall management and efficiency of medical insurance funds [1][4]. Group 1: Key Focus Areas for 2026 - The national medical insurance system will focus on consolidating universal coverage and improving the basic medical insurance system [1]. - There will be support for the development of commercial health insurance to establish a multi-tiered medical security system [1]. - Strengthening the management of medical insurance funds to ensure their safety is a priority [1]. Group 2: Childbirth Cost Reduction - The initiative aims for childbirth to be essentially free across the country by 2026, with specific measures to include flexible employment workers and migrant workers in maternity insurance coverage [4]. - Seven provinces, including Jilin, Jiangsu, and Shandong, have already achieved the goal of making childbirth free [4]. - The plan includes enhancing prenatal care coverage and ensuring direct payment of maternity benefits to insured individuals [4]. Group 3: Long-term Care Insurance Development - The long-term care insurance system currently covers approximately 300 million insured individuals and has benefited over 3.3 million disabled individuals [5]. - The focus will be on optimizing long-term care services and encouraging commercial insurance institutions to develop related products [5]. Group 4: Fund Management and Efficiency - The article highlights the importance of the proper use of medical insurance funds, which are crucial for public health [8]. - Measures have been taken to combat fraud, with approximately 120 billion yuan recovered over five years [8]. - The implementation of a new payment system and the promotion of real-time settlement of medical insurance funds are planned for 2026 [10]. Group 5: Drug Procurement and Innovation - The national centralized drug procurement has become a regular practice, with the latest round including 55 drugs aimed at stabilizing clinical use and ensuring quality [12]. - The introduction of a commercial insurance drug directory aims to cover innovative drugs that exceed basic insurance coverage [13]. - The focus on digitalization and artificial intelligence in medical insurance governance is expected to enhance policy implementation and industry vitality [14][15].